Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DHDDS antisense RNA 1 (DHDDS-AS1) is a long non-coding RNA gene located antisense to the DHDDS (dehydrodolichyl diphosphate synthase subunit) gene. As an antisense transcript, it may regulate the expression of DHDDS or play a role in RNA-mediated gene regulatory mechanisms, but its precise function, molecular mechanism, and clinical significance have not been characterized in current literature[3][4]. No evidence supports its classification as a direct therapeutic target such as an enzyme, receptor, or transporter. Current data sources (GeneCards, BioGPS, NCBI gene records) provide only basic gene annotation and transcript information for DHDDS-AS1, with no functional studies, disease association, or known interacting drugs, distinguishing it from the adjacent protein-coding DHDDS gene[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DHDDS antisense RNA 1 (DHDDS-AS1).